LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma

BMC Clinical Pathology

Volumn 13, Issue 1, 2013, Pages

  Sirivanichsuntorn, Porntipa ^a   Keelawat, Somboon ^a   Danuthai, Kittipong ^a   Mutirangura, Apiwat ^a   Subbalekha, Keskanya ^a   Kitkumthorn, Nakarin ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Alu element; Laser capture microdissection; Long INterspersed Element 1s (LINE 1s); Methylation; Mucoepidermoid carcinoma (MEC)

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; ALU SEQUENCE; ARTICLE; CELL ISOLATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENRICHMENT CULTURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LONG INTERSPERSED REPEAT; MALE; PREDICTIVE VALUE;

EID: 84875045161     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-13-10     Document Type: Article

References (50)

1. Barnes LEJ, Reichart P, Sidransky D, World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours Lyon: IARC press 2005
2. A clinicopathologic study of 196 intraoral minor salivary gland tumours. Lopes MA, Kowalski LP, da Cunha Santos G, Paes De Almeida O, J Oral Pathol Med 1999 28 6 264 267 10426199 (Pubitemid 29298250)
3. Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases. Vargas PA, Gerhard R, Araujo Filho VJ, de Castro IV, Rev Hosp Clin Fac Med Sao Paulo 2002 57 6 271 276 12612759
4. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Waldron CA, El-Mofty SK, Gnepp DR, Oral Surg Oral Med Oral Pathol 1988 66 3 323 333 10.1016/0030-4220(88)90240-X 2845326
5. Ellis GL, Tumours of the salivary glands Washington: Armed Forced Institute of Pathology 3 1996
6. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Auclair PL, Goode RK, Ellis GL, Cancer 1992 69 8 2021 2030 10.1002/1097-0142(19920415)69:8<2021::AID- CNCR2820690803>3.0.CO;2-7 1544111
7. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, Bodian C, Urken ML, Gnepp DR, Huvos A, Am J Surg Pathol 2001 25 7 835 845 10.1097/00000478-200107000-00001 11420454 (Pubitemid 32594976)
8. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Evans HL, Am J Clin Pathol 1984 81 6 696 701 6731349 (Pubitemid 14076656)
9. Mucoepidermoid carcinoma of salivary glands: a clinicopathologic study of 46 cases. Nascimento AG, Amaral LP, Prado LA, Kligerman J, Silveira TR, Head Neck Surg 1986 8 6 409 417 10.1002/hed.2890080604 3721883
10. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Spiro RH, Huvos AG, Berk R, Strong EW, Am J Surg 1978 136 4 461 468 10.1016/0002-9610(78)90262-3 707726 (Pubitemid 9027654)
11. Cytokeratin profile in mucoepidermoid carcinoma is not related to its histological grading of malignancy. da Silveira EJ, Veras Barros SS, de Amorim RF, Queiroz LM, Freitas Rde A, de Souza LB, Exp Mol Pathol 2006 81 1 72 76 10.1016/j.yexmp.2005.12.001 16445908 (Pubitemid 43946857)
12. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Skalova A, Lehtonen H, von Boguslawsky K, Leivo I, Hum Pathol 1994 25 9 929 935 10.1016/0046-8177(94)90014-0 8088769 (Pubitemid 24292411)
13. Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland. Zhu Q, Tipoe GL, White FH, Anal Quant Cytol Histol 1999 21 4 336 342 10560511 (Pubitemid 29383451)
14. Fusion oncogenes and tumor type specificity-insights from salivary gland tumors. Stenman G, Semin Cancer Biol 2005 15 3 224 235 10.1016/j.semcancer.2005. 01.002 15826837
15. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma. Okumura Y, Miyabe S, Nakayama T, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H, Histopathology 2011 59 1 90 97 10.1111/j.1365-2559.2011.03890.x 21668476
16. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H, Mod Pathol 2009 22 12 1575 1581 10.1038/modpathol.2009.126 19749740
17. A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality. El-Naggar AK, Lovell M, Killary AM, Clayman GL, Batsakis JG, Cancer Genet Cytogenet 1996 87 1 29 33 10.1016/0165-4608(95)00266-9 8646736 (Pubitemid 26113601)
18. Translocation (11;19)(q21;p13.1) in mucoepidermoid carcinoma of salivary gland. Horsman DE, Berean K, Durham JS, Cancer Genet Cytogenet 1995 80 2 165 166 10.1016/0165-4608(94)00187-G 7736438
19. Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma. Nordkvist A, Gustafsson H, Juberg-Ode M, Stenman G, Cancer Genet Cytogenet 1994 74 2 77 83 10.1016/0165-4608(94)90001-9 8019965 (Pubitemid 24208871)
20. H-ras gene mutations in salivary gland mucoepidermoid carcinomas. Yoo J, Robinson RA, Cancer 2000 88 3 518 523 10.1002/(SICI)1097-0142(20000201)88: 3<518::AID-CNCR4>3.0.CO;2-W 10649241 (Pubitemid 30056923)
21. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutirangura A, Oncogene 2004 23 54 8841 8846 10.1038/sj.onc.1208137 15480421 (Pubitemid 39593298)
22. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Piyathilake CJ, Frost AR, Bell WC, Oelschlager D, Weiss H, Johanning GL, Niveleau A, Heimburger DC, Grizzle WE, Hum Pathol 2001 32 8 856 862 10.1053/hupa.2001.26471 11521231 (Pubitemid 32803988)
23. LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor. Kitkumthorn N, Mutirangura A, Oral Dis 2010 16 3 286 291 10.1111/j.1601-0825.2009.01640.x 20374511
24. The impact of L1 retrotransposons on the human genome. Kazazian HH Jr, Moran JV, Nat Genet 1998 19 1 19 24 10.1038/ng0598-19 9590283 (Pubitemid 28242017)
25. Initial sequencing and analysis of the human genome. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Nature 2001 409 6822 860 921 10.1038/35057062 11237011 (Pubitemid 32165345)
26. Biology of mammalian L1 retrotransposons. Ostertag EM, Kazazian HH Jr, Annu Rev Genet 2001 35 501 538 10.1146/annurev.genet.35.102401.091032 11700292 (Pubitemid 34032985)
27. DNA methylation changes in ex-adenoma carcinoma of the large intestine. Kwon HJ, Kim JH, Bae JM, Cho NY, Kim TY, Kang GH, Virchows Arch 2010 457 4 433 441 10.1007/s00428-010-0958-9 20711609
28. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. Park SY, Yoo EJ, Cho NY, Kim N, Kang GH, J Pathol 2009 219 4 410 416 10.1002/path.2596 19639607
29. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, Tresukosol D, Mutirangura A, Int J Gynecol Cancer 2008 18 4 711 717 10.1111/j.1525-1438.2007.01117.x 17944913 (Pubitemid 352020191)
30. Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix. Shuangshoti S, Hourpai N, Pumsuk U, Mutirangura A, Asian Pac J Cancer Prev 2007 8 2 307 309 17696752
31. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Tangkijvanich P, Hourpai N, Rattanatanyong P, Wisedopas N, Mahachai V, Mutirangura A, Clin Chim Acta 2007 379 1-2 127 133 17303099 (Pubitemid 46389509)
32. Differential repetitive DNA methylation in multiple myeloma molecular subgroups. Bollati V, Fabris S, Pegoraro V, Ronchetti D, Mosca L, Deliliers GL, Motta V, Bertazzi PA, Baccarelli A, Neri A, Carcinogenesis 2009 30 8 1330 1335 10.1093/carcin/bgp149 19531770
33. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, Kim D, Kang GH, J Pathol 2007 211 3 269 277 10.1002/path.2106 17139617 (Pubitemid 46172702)
34. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Int J Cancer 2008 122 12 2767 2773 10.1002/ijc.23470 18366060 (Pubitemid 351631379)
35. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Schulz WA, Elo JP, Florl AR, Pennanen S, Santourlidis S, Engers R, Buchardt M, Seifert HH, Visakorpi T, Genes Chromosomes Cancer 2002 35 1 58 65 10.1002/gcc.10092 12203790 (Pubitemid 34847869)
36. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Choi IS, Estecio MR, Nagano Y, Kim Do H, White JA, Yao JC, Issa JP, Rashid A, Mod Pathol 2007 20 7 802 810 10.1038/modpathol.3800825 17483816 (Pubitemid 46933452)
37. Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas. Kim MJ, White-Cross JA, Shen L, Issa JP, Rashid A, Mod Pathol 2009 22 3 442 449 10.1038/modpathol.2008.203 19136926
38. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G, PLoS Genet 2010 6 4 1000917 10.1371/journal.pgen.1000917 20421991
39. Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Woloszynska-Read A, Mhawech-Fauceglia P, Yu J, Odunsi K, Karpf AR, Clin Cancer Res 2008 14 11 3283 3290 10.1158/1078-0432.CCR-07-5279 18519754
40. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH, Clin Cancer Res 2009 15 3 812 820 10.1158/1078-0432.CCR-08-0266 19188151
41. Improved measurement of LINE-1 sequence methylation for cancer detection. Pobsook T, Subbalekha K, Sannikorn P, Mutirangura A, Clin Chim Acta 2011 412 3-4 314 321 21078311
42. Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Kitkumthorn N, Mutirangura A, Clin Epigenet 2011 2 315 330 10.1007/s13148-011-0032-8
43. Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Guzzo M, Andreola S, Sirizzotti G, Cantu G, Ann Surg Oncol 2002 9 7 688 695 10.1007/BF02574486 12167584 (Pubitemid 34857987)
44. [Histopathological grading and clinical features of patients with mucoepidermoid carcinoma of the salivary glands]. Monoo K, Sageshima M, Ito E, Nishihira S, Ishikawa K, Nihon Jibiinkoka Gakkai Kaiho 2003 106 3 192 198 10.3950/jibiinkoka.106.192 12708033 (Pubitemid 36417611)
45. Patterns and Possible Roles of LINE-1 Methylation Changes in Smoke-Exposed Epithelia. Wangsri S, Subbalekha K, Kitkumthorn N, Mutirangura A, PLoS One 2012 7 9 45292 10.1371/journal.pone.0045292 23028911
46. Codon72 polymorphism in the p53 tumor suppressor gene in oral lichen planus lesions in a Thai population. Yanatatsaneeji P, Kitkumthorn N, Dhammawipark C, Rabalert J, Patel V, Mutirangura A, Asian Pac J Cancer Prev 2010 11 4 1137 1141 21133638
47. LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients. Kitkumthorn N, Tuangsintanakul T, Rattanatanyong P, Tiwawech D, Mutirangura A, Clin Chim Acta 2012 413 9-10 869 874 10.1016/j.cca.2012.01.024 22326975
48. LINE-1 and Alu Methylation Patterns in Lymph Node Metastasis of Head and Neck Cancers. Kitkumthorn N, Keelawat S, Rattanatanyong P, Mutirangura A, Asian Pac J Cancer Prev 2012 13 9 4469 4475 10.7314/APJCP.2012.13.9.4469 23167363
49. Role of cancer-associated fibroblasts in breast cancer development and prognosis. Aboussekhra A, Int J Dev Biol 2011 55 7-9 841 849 22161840
50. Salivary mucoepidermoid carcinoma: revisited. Luna MA, Adv Anat Pathol 2006 13 6 293 307 10.1097/01.pap.0000213058.74509.d3 17075295 (Pubitemid 44673445)